3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
3
Phase 1
3
Phase 3
2
Phase 2
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
2
Conditions
Melanoma
18
Carcinoma, Non-Small-Cell Lung
10
Carcinoma, Renal Cell
9
Kidney Neoplasms
4
Stomach Neoplasms
3
Mesothelioma
3
Lung Neoplasms
3
Diabetes Mellitus, Insulin-Dependent, 12
3
Carcinoma, Hepatocellular
3
Skin Neoplasms
2
Prostatic Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasm Metastasis
2
Mesothelioma, Malignant
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Various Advanced Cancer
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Recurrent Squamous Cell Lung Carcinoma
1
Recurrence
1
Non-Small Cell Lung Cancer Metastatic
1
Neoplasms
1
Melanoma, Cutaneous Malignant
1
Lymphatic Metastasis
1
Interventions
Cisplatin
47
Radiotherapy
37
Fluorouracil
23
Cetuximab
17
pembrolizumab
11
Carboplatin
11
Paclitaxel
8
Docetaxel
8
Radiotherapy, Intensity-Modulated
6
Chemotherapy, Adjuvant
6
Surgical Procedures, Operative
5
Standard of Care
5
nimotuzumab
4
Methotrexate
4
Gabapentin
4
Drug Therapy
4
Afatinib
4
Radiotherapy, Conformal
3
Radiation
3
Porfiromycin
3
Nivolumab
3
Neoadjuvant Therapy
3
Fibroblast Growth Factor 7
3
Bleomycin
3
zalutumumab
2
sargramostim
2
epacadostat
2
Tranexamic Acid
2
Tirapazamine
2
Pilocarpine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Head and Neck Neoplasms
×
Ipilimumab
×
Clear all
NCT02741570
2023-09-21
CheckMate 651
Bristol-Myers Squibb
Phase 3
Completed
947 enrolled
19 charts
NCT03700905
2023-05-23
IMSTAR-HN
Universitätsklinikum Hamburg-Eppendorf
Phase 3
Unknown
276 enrolled